- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 58 x IOD: IODIDE ION(Non-functional Binders)
IOD.2: 2 residues within 4Å:- Chain A: L.62, K.65
Ligand excluded by PLIPIOD.3: 3 residues within 4Å:- Chain A: R.311
- Chain D: N.343, T.392
Ligand excluded by PLIPIOD.4: 2 residues within 4Å:- Chain A: H.50, R.373
Ligand excluded by PLIPIOD.5: 3 residues within 4Å:- Chain A: D.79, A.80, I.129
Ligand excluded by PLIPIOD.6: 4 residues within 4Å:- Chain A: M.366, E.368
- Chain B: R.218, D.221
Ligand excluded by PLIPIOD.7: 3 residues within 4Å:- Chain A: Y.132, K.141, D.186
Ligand excluded by PLIPIOD.8: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.9: 2 residues within 4Å:- Chain A: R.287, N.288
Ligand excluded by PLIPIOD.10: 5 residues within 4Å:- Chain A: E.149, R.160, T.161, A.175
- Ligands: IOD.14
Ligand excluded by PLIPIOD.11: 2 residues within 4Å:- Chain A: E.284, W.285
Ligand excluded by PLIPIOD.12: 3 residues within 4Å:- Chain A: V.261, R.264, V.338
Ligand excluded by PLIPIOD.13: 2 residues within 4Å:- Chain A: A.258, A.259
Ligand excluded by PLIPIOD.14: 3 residues within 4Å:- Chain A: G.151, R.160
- Ligands: IOD.10
Ligand excluded by PLIPIOD.15: 1 residues within 4Å:- Chain A: V.216
Ligand excluded by PLIPIOD.16: 2 residues within 4Å:- Chain A: R.134, P.135
Ligand excluded by PLIPIOD.20: 3 residues within 4Å:- Chain B: R.311
- Chain C: N.343, T.392
Ligand excluded by PLIPIOD.21: 3 residues within 4Å:- Chain B: A.49, H.50, R.373
Ligand excluded by PLIPIOD.22: 4 residues within 4Å:- Chain B: P.59, E.61, L.62, K.65
Ligand excluded by PLIPIOD.23: 1 residues within 4Å:- Chain B: E.51
Ligand excluded by PLIPIOD.24: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.25: 2 residues within 4Å:- Chain B: D.79, A.80
Ligand excluded by PLIPIOD.26: 2 residues within 4Å:- Chain B: H.169, P.241
Ligand excluded by PLIPIOD.27: 4 residues within 4Å:- Chain A: R.218, D.221
- Chain B: M.366, E.368
Ligand excluded by PLIPIOD.28: 3 residues within 4Å:- Chain B: V.261, R.264, V.338
Ligand excluded by PLIPIOD.29: 1 residues within 4Å:- Chain B: R.226
Ligand excluded by PLIPIOD.30: 1 residues within 4Å:- Chain B: Q.327
Ligand excluded by PLIPIOD.31: 3 residues within 4Å:- Chain B: P.150, G.151
- Ligands: IOD.32
Ligand excluded by PLIPIOD.32: 4 residues within 4Å:- Chain B: E.149, T.161, A.175
- Ligands: IOD.31
Ligand excluded by PLIPIOD.33: 2 residues within 4Å:- Chain B: E.284, W.285
Ligand excluded by PLIPIOD.37: 2 residues within 4Å:- Chain C: L.62, K.65
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain B: N.343, T.392
- Chain C: R.311
Ligand excluded by PLIPIOD.39: 2 residues within 4Å:- Chain C: H.50, R.373
Ligand excluded by PLIPIOD.40: 3 residues within 4Å:- Chain C: D.79, A.80, I.129
Ligand excluded by PLIPIOD.41: 4 residues within 4Å:- Chain C: M.366, E.368
- Chain D: R.218, D.221
Ligand excluded by PLIPIOD.42: 3 residues within 4Å:- Chain C: Y.132, K.141, D.186
Ligand excluded by PLIPIOD.43: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.44: 2 residues within 4Å:- Chain C: R.287, N.288
Ligand excluded by PLIPIOD.45: 5 residues within 4Å:- Chain C: E.149, R.160, T.161, A.175
- Ligands: IOD.49
Ligand excluded by PLIPIOD.46: 2 residues within 4Å:- Chain C: E.284, W.285
Ligand excluded by PLIPIOD.47: 3 residues within 4Å:- Chain C: V.261, R.264, V.338
Ligand excluded by PLIPIOD.48: 2 residues within 4Å:- Chain C: A.258, A.259
Ligand excluded by PLIPIOD.49: 3 residues within 4Å:- Chain C: G.151, R.160
- Ligands: IOD.45
Ligand excluded by PLIPIOD.50: 1 residues within 4Å:- Chain C: V.216
Ligand excluded by PLIPIOD.51: 2 residues within 4Å:- Chain C: R.134, P.135
Ligand excluded by PLIPIOD.55: 3 residues within 4Å:- Chain A: N.343, T.392
- Chain D: R.311
Ligand excluded by PLIPIOD.56: 3 residues within 4Å:- Chain D: A.49, H.50, R.373
Ligand excluded by PLIPIOD.57: 4 residues within 4Å:- Chain D: P.59, E.61, L.62, K.65
Ligand excluded by PLIPIOD.58: 1 residues within 4Å:- Chain D: E.51
Ligand excluded by PLIPIOD.59: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.60: 2 residues within 4Å:- Chain D: D.79, A.80
Ligand excluded by PLIPIOD.61: 2 residues within 4Å:- Chain D: H.169, P.241
Ligand excluded by PLIPIOD.62: 4 residues within 4Å:- Chain C: R.218, D.221
- Chain D: M.366, E.368
Ligand excluded by PLIPIOD.63: 3 residues within 4Å:- Chain D: V.261, R.264, V.338
Ligand excluded by PLIPIOD.64: 1 residues within 4Å:- Chain D: R.226
Ligand excluded by PLIPIOD.65: 1 residues within 4Å:- Chain D: Q.327
Ligand excluded by PLIPIOD.66: 3 residues within 4Å:- Chain D: P.150, G.151
- Ligands: IOD.67
Ligand excluded by PLIPIOD.67: 4 residues within 4Å:- Chain D: E.149, T.161, A.175
- Ligands: IOD.66
Ligand excluded by PLIPIOD.68: 2 residues within 4Å:- Chain D: E.284, W.285
Ligand excluded by PLIP- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.17: 5 residues within 4Å:- Chain A: Q.276, A.310, D.314, R.317
- Chain D: L.399
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Q.276, A:Q.276, A:R.317, A:R.317
EDO.35: 5 residues within 4Å:- Chain B: Q.276, A.310, D.314, R.317
- Chain C: L.399
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Q.276, B:Q.276, B:R.317, B:R.317
EDO.52: 5 residues within 4Å:- Chain B: L.399
- Chain C: Q.276, A.310, D.314, R.317
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:Q.276, C:Q.276, C:R.317, C:R.317
EDO.70: 5 residues within 4Å:- Chain A: L.399
- Chain D: Q.276, A.310, D.314, R.317
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:Q.276, D:Q.276, D:R.317, D:R.317
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
FDA.18: 27 residues within 4Å:- Chain A: I.115, L.145, A.146, I.147, T.148, G.152, G.153, S.154, Y.178, I.179, T.180, K.222, I.380, I.383, G.385, T.387, E.389
- Chain B: R.289, T.291, L.296, R.299, Q.358, L.359, G.361, G.362, M.366
- Chain D: Q.300
31 PLIP interactions:22 interactions with chain A, 8 interactions with chain B, 1 interactions with chain D- Hydrophobic interactions: A:Y.178, A:K.222, A:I.380
- Hydrogen bonds: A:L.145, A:I.147, A:T.148, A:T.148, A:T.148, A:G.153, A:S.154, A:S.154, A:T.180, A:T.180, A:T.180, A:G.385, A:T.387, A:T.387, A:E.389, B:T.291, B:T.291, B:Q.358, B:G.362, D:Q.300
- Water bridges: A:G.152, A:D.155, A:G.386, A:G.386, B:R.289, B:M.363
- Salt bridges: B:R.289, B:R.289
FDA.34: 27 residues within 4Å:- Chain A: R.289, T.291, F.292, L.296, R.299, Q.358, L.359, G.361, G.362, M.366
- Chain B: I.115, L.145, I.147, T.148, G.152, G.153, S.154, Y.178, I.179, T.180, K.222, W.225, I.380, I.383, T.387, E.389
- Chain C: Q.300
27 PLIP interactions:20 interactions with chain B, 6 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: B:Y.178, B:K.222, B:W.225, B:I.380
- Hydrogen bonds: B:L.145, B:I.147, B:T.148, B:T.148, B:T.148, B:G.153, B:S.154, B:S.154, B:T.180, B:T.180, B:G.385, B:T.387, A:T.291, A:T.291, A:Q.358, A:G.362, C:Q.300
- Water bridges: B:Y.178, B:Y.178, B:G.386, B:G.386
- Salt bridges: A:R.289, A:R.289
FDA.53: 27 residues within 4Å:- Chain B: Q.300
- Chain C: I.115, L.145, A.146, I.147, T.148, G.152, G.153, S.154, Y.178, I.179, T.180, K.222, I.380, I.383, G.385, T.387, E.389
- Chain D: R.289, T.291, L.296, R.299, Q.358, L.359, G.361, G.362, M.366
30 PLIP interactions:1 interactions with chain B, 22 interactions with chain C, 7 interactions with chain D- Hydrogen bonds: B:Q.300, C:L.145, C:I.147, C:T.148, C:T.148, C:T.148, C:G.153, C:S.154, C:S.154, C:T.180, C:T.180, C:G.385, C:T.387, D:T.291, D:T.291, D:Q.358, D:G.362
- Hydrophobic interactions: C:Y.178, C:K.222, C:I.380
- Water bridges: C:G.152, C:D.155, C:Y.178, C:Y.178, C:T.180, C:G.386, C:G.386, D:R.289
- Salt bridges: D:R.289, D:R.289
FDA.69: 27 residues within 4Å:- Chain A: Q.300
- Chain C: R.289, T.291, F.292, L.296, R.299, Q.358, L.359, G.361, G.362, M.366
- Chain D: I.115, L.145, I.147, T.148, G.152, G.153, S.154, Y.178, I.179, T.180, K.222, W.225, I.380, I.383, T.387, E.389
29 PLIP interactions:21 interactions with chain D, 7 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: D:Y.178, D:K.222, D:W.225, D:I.380
- Hydrogen bonds: D:L.145, D:I.147, D:T.148, D:T.148, D:T.148, D:G.153, D:S.154, D:S.154, D:T.180, D:T.180, D:T.180, D:G.385, D:T.387, D:T.387, D:E.389, C:T.291, C:T.291, C:Q.358, C:G.362, A:Q.300
- Water bridges: D:G.386, D:G.386, C:M.363
- Salt bridges: C:R.289, C:R.289
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J Struct Funct Genomics (2011)
- Release Date
- 2010-09-01
- Peptides
- Acyl-CoA dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 58 x IOD: IODIDE ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J. et al., SAD phasing using iodide ions in a high-throughput structural genomics environment. J Struct Funct Genomics (2011)
- Release Date
- 2010-09-01
- Peptides
- Acyl-CoA dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B